<ѻý>Oral Drug Active in Teens With Atopic Dermatitisѻý> Significant improvement at 12 weeks in 42-46% by one index, 68-72% by another Aug 24, 2021
<ѻý>Dual IL-17 Inhibitor Achieves Deep Responses in Hidradenitis Suppurativaѻý> Bimekizumab outclasses placebo, compares favorably with adalimumab Aug 20, 2021
<ѻý>Adalimumab Adds to Surgery Benefits for Hidradenitis Suppurativaѻý> Significantly higher response rates before and after surgery with biologic agent Aug 18, 2021
<ѻý>JAK Inhibitor Tops Mab for Eczemaѻý> New disease-modifying treatment option on the horizon Aug 04, 2021
<ѻý>Third Dose a Charm in Israel? Door-to-Door 'Goons'; Cervids Catch COVID, Too!ѻý> A daily roundup of news on COVID-19 and the rest of medicine Jul 30, 2021
<ѻý>Acne Takes a Toll on Women's Mental Health, Quality of Lifeѻý> Almost half reported self-consciousness, adverse effects on professional, social, personal lives Jul 28, 2021
<ѻý>FDA Approves IVIG for Dermatomyositisѻý> Octagam 10% lands indication for adults following results of ProDERM trial Jul 20, 2021
<ѻý>Shingles Risk Slashed in IBD Patients After Vaccineѻý> Study found certain medications also showed lower incidence rates Jul 20, 2021
<ѻý>Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Saysѻý> New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
<ѻý>Physician Organizations Challenge PA Name Changeѻý> The AMA and AOA release statements against the rebrand Jun 09, 2021
<ѻý>Unhealthy Quest for Lighter Skin Fuels Bleaching Epidemicѻý> Breaking the centuries-old cycle of myths about skin color May 25, 2021
<ѻý>Rituximab Tops Mycophenolate Mofetil for Pemphigus Vulgarisѻý> Sustained complete response rate four times higher with anti-CD20 antibody May 19, 2021
<ѻý>Is This the Most TikTok'd COVID Vaccine Side Effect?ѻý> Dermatologists say there's no issue: 'Happy filling, happy vaccinating' May 12, 2021
<ѻý>No Clarity for Role of Laser Therapy in Vulvar Lichen Sclerosusѻý> Mixed results from two small randomized clinical trials May 10, 2021
<ѻý>Another COVID-19 Side Effect: 'Zoom Dysmorphia'ѻý> As people spend more time on camera, many of them like themselves less and less May 06, 2021
<ѻý>First Detailed Look at COVID Vaccine Skin Reactionsѻý> Mostly mild, self-limiting reactions and no serious adverse reactions May 05, 2021
<ѻý>Rapid Improvement in Atopic Dermatitis With New JAK1 Inhibitorѻý> Plus: First-in-class drug shows promise in AD, BTK inhibitor active in pemphigus May 03, 2021
<ѻý>Topical JAK Inhibitor Shows Promise in Vitiligoѻý> Half of patients had 90% improvement after 2 years of treatment Apr 30, 2021
<ѻý>High Rate of Hyperhidrosis Relief With Topical Agentѻý> Benefit for 86% of patients treated with sofpironium bromide Apr 29, 2021
<ѻý>Rapid Improvement in Atopic Dermatitis With Topical JAK Inhibitorѻý> Disease activity index improved as early as week 1 with delgocitinib cream Apr 27, 2021
<ѻý>Significant Improvement in Hand Eczema With Pan-JAK Inhibitorѻý> Disease activity indicators reduced, no safety signals with gusacitinib versus placebo Apr 26, 2021
<ѻý>Big Win in Psoriasis for Dual IL-17A/17F Inhibitorѻý> Significant differences in clearance with bimekizumab vs secukinumab at all time points Apr 23, 2021
<ѻý>Op-Ed: Dermatology Needs Lower Costs and Better Careѻý> A proposal for value-based care Apr 21, 2021
<ѻý>Nivolumab Alone Prevails in Resected Melanomaѻý> Adding ipilimumab in adjuvant setting failed to improve relapse-free survival Apr 11, 2021
<ѻý>For Enthesitis in Psoriatic Arthritis, Target IL-23ѻý> Targeted agent provides relief for many PsA patients Apr 08, 2021
<ѻý>COVID Triggers Novel Infectious Skin Condition in Teenѻý> Mild case led to unusual effects a week later Apr 07, 2021
<ѻý>JAK Inhibitor Promising in Psoriatic Arthritisѻý> Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
<ѻý>Using the Skin Microbiome to Control Atopic Dermatitisѻý> Bacteria-based therapy shows promise in proof-of-concept trial Mar 01, 2021
<ѻý>Young Hidradenitis Suppurativa Patients See Lags in Careѻý> Diagnosis typically came years after disease onset; providers claim lack of knowledge on HS pain Feb 24, 2021
<ѻý>Want Data on Recently Approved Actinic Keratosis Drug? Here You Goѻý> Phase III trial now published in full for topical anti-proliferative treatment Feb 10, 2021
<ѻý>Monoclonal Antibody Highly Effective in Phase III Psoriasis Trialѻý> Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
<ѻý>Brain Tumor Risk Upped With Synthetic Progestogenѻý> Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
<ѻý>High Potassium No Threat With Spironolactoneѻý> Despite guidelines, many still monitoring K levels in young women with acne, researchers find Jan 27, 2021
<ѻý>Masculinizing Hormone Therapy Tied to Acne in Transmenѻý> Acne also linked with depression and anxiety; Accutane may be treatment option Jan 20, 2021
<ѻý>Derm Symptoms Signal MIS-C in Kidsѻý> Case series shows mucocutaneous findings in most children Dec 09, 2020
<ѻý>Renewed Concerns About Finasteride and Mental Healthѻý> Database study links popular alopecia treatment with increased risks of suicidality, depression Nov 27, 2020
<ѻý>Eva Mendes Gets Mono-Threadingѻý> A look at the movie star's recent beauty procedure Nov 24, 2020
<ѻý>More Evidence for Ligelizumab in Chronic Hivesѻý> Anti-IgE drug showed improved activity in omalizumab-treated patients with inadequate symptom control Nov 17, 2020
<ѻý>Watch for Suicidality in Men on Propeciaѻý> Analysis found high number of psychological-related reports Nov 11, 2020
<ѻý>TYK2 Inhibition Promising in Psoriatic Arthritisѻý> Phase II study found significant benefits for two doses of novel agent Nov 10, 2020